Seeing Is Believing
Currently out of the existing stock ratings of Reni Benjamin, 138 are a BUY (89.61%), 14 are a HOLD (9.09%), 2 are a SELL (1.3%).
Analyst Reni Benjamin works at JMP with a stock forecast success ratio of 42.76% fulfilled within 163.8 days on average.
Reni Benjamin’s has documented 286 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BCAB, Bioatla at 28-Mar-2024.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA CORP) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
43
$20.33 (89.68%)
43
2 months 4 days ago
0/11 (0%)
$19.8 (85.34%)
Buy
55
$32.33 (142.61%)
57
2 months 4 days ago
1/7 (14.29%)
$31.8 (137.07%)
83
Buy
32
$9.33 (41.16%)
44
4 months 5 days ago
1/9 (11.11%)
$13.92 (76.99%)
174
Buy
65
$42.33 (186.72%)
65
5 months 17 days ago
0/5 (0%)
$49.66 (323.73%)
40
$17.33 (76.44%)
42
5 months 22 days ago
0/5 (0%)
$24.47 (157.57%)
Which stock is Reni Benjamin is most bullish on?
Which stock is Reni Benjamin is most reserved on?
What Year was the first public recommendation made by Reni Benjamin?